Search results for "R&D"
showing 10 items of 87 documents
Open innovation: A real option to restore value to the biopharmaceutical R&D
2014
The pharmaceutical landscape has changed, and new business models, based on alliances, are increasingly being adopted in this industry. Biotechnology advances have pushed this development, and pooling complementary resources coming from incumbents and newcomers is a key skill to succeed: these are the premises for a quick spread of the open innovation (OI) paradigm in this industry. R&D portfolio selection needs R&D project evaluation, and Real Options Analysis (ROA) is acknowledged as a powerful tool to evaluate uncertain projects that have an intrinsic flexibility. The present research aims to foster the use of ROA in the OI field in order to encourage firms to undertake this innovation mode…
A real options based model to select a balanced R&D portfolio
2011
The R&D process in the pharmaceutical industry has a long and dynamic life then it is an ideal field of application for ROA. Actually, ROA implementation, as widely demonstrated in literature, is narrowed to very limited cases because its perceived complexity. This research wants to suggest a simplified method, respect the ones available in literature, that could foster the use of ROA: we built up an integer linear programming model, based on a model available in literature, useful for selecting a balanced R&D portfolio from a set of candidate drugs. The model has been tested through a case study.
An affordable way to implement real options to select optimal R&D portfolio
2011
Real option Analysis (ROA) is acknowledged as a powerful tool to evaluate uncertain projects whose uncertainty depends heavily on alternatives available along the project life. The R&D process in the pharmaceutical industry has a long and dynamic life then it is an ideal field of application for ROA. Actually, ROA implementation, as widely demonstrated in literature, is narrowed to very limited cases because its perceived complexity. This research wants to suggest a simplified method, respect the ones available in literature, that could foster the use of ROA: we built up an integer linear programming model, based on a model available in literature, useful for selecting the optimal R&D produ…
A real options based support system to open innovation
2012
Pharmaceutical R&D process (PR&DP) has been deeply investigated by different streams of literature; the interest is due to the strategic implication of the related decisions undertaken. The PR&DP has been revolutionised by the biotech advent and as a consequence R&D managers cannot avoid to consider Open Innovation paradigm during this decision process. Starting from a Real Option optimization model available in literature, the paper aims at proposing a decision support system (DSS) able to suggest the candidate products to be included in the best R&D portfolio varying input parameters (resilient products), to provide a products Pareto analysis that aims at individuating the products for wh…
The effects of sharing sustainable technology R&D on EU competition law
2022
This paper explores the significance of EU competition system in attaining envisioned sustainability targets by analysing the prospective symbiosis between European competition and patent law. Furthermore, this research evaluates both the plausible threats in the internal market stemming from lenient competition legislation as well as highlighting the apparent benefits of coordinating EU intellectual property and antitrust law to facilitate innovation. The goal of this research is to determine whether such polar opposites can indeed be merged into sustainable competition policy or will it end up fostering breeding ground for collusive behaviour in the common market.
Role of collaborative supply chain of innovation in firm’s performance
2014
This work depicts the Supply Chain of Innovation (SCoI) including only those kinds of relationships related to the purchase and selling of R&D commodities. The theoretical framework represents the propensity of a firm in improving its innovation performance thanks to its collaboration experience and positioning in SCoI. We validate our theoretical framework on a sample of 208 biotechnology companies involved in 814 SCoI agreements. Our results show the positive direct impact of SCoI collaboration experience on innovation performance and a mediating role of positioning in SCoI on the abovementioned link.
Les pôles de compétitivité structurent-ils les trajectoires professionnelles des jeunes diplômés ?
2012
National audience; La création des pôles de compétitivité en France a permis un investissement massif dans des projets de R&D dans certains territoires. S'appuyant sur le développement de synergie entre les entreprises, les centres de recherche et les établissements de formations, ces pôles devraient favoriser une politique de ressources humaines propices à l'innovation. Notre recherche propose d'examiner l'effet de la création de ces pôles sur le salaire des diplômés des écoles d'ingénieurs. Une méthode de différences de différences est utilisée pour comparer les rémunérations des jeunes diplômés avant et après la création des pôles. Les résultats montrent des effets positifs de la créatio…
French engineering graduates in corporate R&D: is it worthwhile?
2009
09054; In the early 1990s, several studies pointed out a significant gap in earnings between engineers in private firms working in Research and Development (R&D) and those in other activities. The purpose of this article is to assess, from conventional Mincerian models, to what extent these findings are still valid. The different levels of responsibility and job satisfaction of engineers in both types of activities are also analysed. The results clearly suggest a lower remuneration for engineers working in R&D in comparison to other activities, all things being equal. On the other hand, engineers involved in R&D activities have a greater dissatisfaction about the remuneration they receive, …
French Engineering Graduates in Corporate R & D : Is it worthwhile ?
2008
08010 - 14 p.; At the beginning of the 1990s, Beltramo, Bourdon and Paul presented a report for the French Commissariat au Plan on the prospect for the labour market for scientists, and other papers, which showed earnings differences between engineering graduates performing tasks in R&D or not (the first ones receiving 7% less than the others, other parameters taken into consideration). The objective of this paper is to assess to what extent, 15 years later, these results, which indicated lower earnings for researchers, is still valid. The data used in this study is similar to that in our former work. The data is generated from the survey launched each year (each two years until 2002) by th…
Le marché du travail des scientifiques : capital humain, incitations, proximité
2011
The aim of that thesis is to bring a micro level contribution to the economics of innovation when using original datasets on the French case. Here the manuscript is structured in three chapters: the labour market of scientists and engineers, the incentives for innovation in the private sector and the existence of spatial spillovers in the school to work transition for graduates in science and engineering (S & I). In the first chapter of this thesis, we focus on the labour market for scientists and engineers. First, we identify the different characteristics of this labour market. We then analyze the determinants of access to R & D for young graduates in S & I. Finally, we question more broad…